In vitro and in vivo antibacterial activities of S-1090, a new oral cephalosporin, in the fields of obstetrics and gynecology.
S-1090 is a new synthetic, nonesterified, oral cephalosporin with a broad spectrum of antibacterial activity. The activities of S-1090 against the causative organisms in the fields of obstetrics and gynecology are superior to those of the currently prescribed oral cephems, cefdinir, cefpodoxime, and cefaclor. The in vivo efficacy of S-1090 was evaluated using uterine endometritis of model rats. The accumulation of neutrophils in the uterus in the S-1090-treated group was milder than that in the nontreated group, and the same was true for the bacteriological response. S-1090 is a promising oral cephalosporin antibiotic for the treatment of infections in the fields of obstetrics and gynecology.
Mikamo
H
H
Department of Obstetrics and Gynecology, School of Medicine, Gifu University, Japan.
Kawazoe
K
K
Sato
Y
Y
Izumi
K
K
Tamaya
T
T
D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy*; D002511:Cephalosporins / Q000494:pharmacology* / Q000627:therapeutic use; D004195:Disease Models, Animal; D004716:Endometritis / Q000188:drug therapy* / Q000382:microbiology / Q000662:veterinary; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy; D051381:Rats; D017207:Rats, Sprague-Dawley; D014599:Uterus / Q000382:microbiology / Q000473:pathology
D002511:Cephalosporins; C098102:S 1090